EPA guidance on the early detection of clinical high risk states of psychoses

European Psychiatry

Volumn 30, Issue 3, 2015, Pages 405-416

  Schultze Lutter, F ^a   Michel, C ^a   Schmidt, S J ^a   Schimmelmann, B G ^a   Maric, N P ^c   Salokangas, R K R ^d   Riecher Rossler A ^e   van der Gaag, M ^f,g   Nordentoft, M ^h   Raballo, A ^i,j   Meneghelli, A ^k   Marshall, M ^l,m   Morrison, A ^l,n   Ruhrmann, S ^b   Klosterkotter J ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF COLOGNE   (Germany)

^c UNIVERSITY OF BELGRADE   (Serbia)

^d UNIVERSITY OF TURKU   (Finland)

^e UNIVERSITY OF BASEL   (Switzerland)

^f VU UNIVERSITY AMSTERDAM   (Netherlands)

^g PARNASSIA PSYCHIATRIC INSTITUTE   (Netherlands)

^h UNIVERSITY OF COPENHAGEN   (Denmark)

ⁱ Reggio Emilia County Health System   (Italy)

^j Regione Emilia Romagna   (Italy)

^k OSPEDALE NIGUARDA CA GRANDA   (Italy)

^l UNIVERSITY OF MANCHESTER   (United Kingdom)

^m LANCASHIRE CARE NHS FOUNDATION TRUST   (United Kingdom)

ⁿ GREATER MANCHESTER MENTAL HEALTH NHS FOUNDATION TRUST   (United Kingdom)

more..

Author keywords

Attenuated psychotic symptoms (APS); Children and adolescents; Cognitive disturbances (COGDIS); Meta analysis; Prevention of psychosis in Europe; Transient psychotic symptoms (BLIPS)

Indexed keywords

ADOLESCENT; ARTICLE; CHILD; COGNITIVE DEFECT; COMORBIDITY; FOLLOW UP; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MEDICAL SOCIETY; PREVALENCE; PRIORITY JOURNAL; PSYCHOSIS; SENSITIVITY ANALYSIS; SUBSTANCE USE; ADULT; COGNITION DISORDERS; EARLY DIAGNOSIS; EARLY INTERVENTION; FEMALE; MALE; META ANALYSIS; MOOD DISORDERS; PRACTICE GUIDELINE; PSYCHOLOGICAL RATING SCALE; PSYCHOTIC DISORDERS; RISK ASSESSMENT; RISK FACTOR; SCHIZOPHRENIA; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; YOUNG ADULT;

NEUROLEPTIC AGENT;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; CHILD; COGNITION DISORDERS; EARLY DIAGNOSIS; EARLY MEDICAL INTERVENTION; FEMALE; HUMANS; MALE; MOOD DISORDERS; PRACTICE GUIDELINES AS TOPIC; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; RISK ASSESSMENT; RISK FACTORS; SCHIZOPHRENIA; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84926169532     PISSN: 09249338     EISSN: 17783585     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2015.01.010     Document Type: Article

References (136)

1. Addington J., Epstein I., Liu L., French P., Boydell K.M., Zipursky R.B. A randomized controlled trial of cognitive behavioral therapy for individuals at clinical high risk of psychosis. Schizophr Res 2011, 125(1):54-61.
2. Alaghband-Rad J., McKenna K., Gordon C.T., Albus K.E., Hamburger S.D., Rumsey J.M., et al. Childhood-onset schizophrenia: the severity of premorbid course. J Am Acad Child Adolesc Psychiatry 1995, 34(10):1273-1283.
3. American Psychiatric Association Diagnostic and statistical manual of mental disorders (DSM-IV) 1994, American Psychiatric Press, Washington, DC. 4th ed.
4. American Psychiatric Association Diagnostic and statistical manual of mental disorders (DSM-5) 2013, American Psychiatric Press, Washington, DC. 5th ed.
5. Amminger G.P., Schäfer M.R., Papageorgiou K., Klier C.M., Cotton S.M., Harrigan S.M., et al. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch Gen Psychiatry 2010, 67(2):146-154.
6. Ballageer T., Malla A., Manchanda R., Takhar J., Haricharan R. Is adolescent-onset first-episode psychosis different from adult onset?. J Am Acad Child Adolesc Psychiatry 2005, 44(8):782-789.
7. Bartels-Velthuis A.A., van de Willige G., Jenner J.A., van Os J., Wiersma D. Course of auditory vocal hallucinations in childhood: 5-year follow-up study. Br J Psychiatry 2011, 199(4):296-302.
8. Bechdolf A., Thompson A., Nelson B., Cotton S., Simmons M.B., Amminger G.P., et al. Experience of trauma and conversion to psychosis in an ultra-high-risk (prodromal) group. Acta Psychiatr Scand 2010, 121(5):377-384.
9. Bechdolf A., Wagner M., Ruhrmann S., Harrigan S., Putzfeld V., Pukrop R., et al. Preventing progression to first-episode psychosis in early initial prodromal states. Br J Psychiatry 2012, 200(1):22-29.
10. Bertolote J., McGorry P. Early intervention and recovery for young people with early psychosis: consensus statement. Br J Psychiatry 2005, 48(Suppl.):116-119.
11. Bodatsch M., Ruhrmann S., Wagner M., Müller R., Schultze-Lutter F., Frommann I., et al. Prediction of psychosis by mismatch negativity. Biol Psychiatry 2011, 69(10):959-966.
12. Buchy L., Perkins D., Woods S.W., Liu L., Addington J. Impact of substance use on conversion to psychosis in youth at clinical high risk of psychosis. Schizophr Res 2014, 156(2-3):277-280.
13. Campion J., Bhui K., Bhugra D. European Psychiatric Association (EPA) guidance on prevention of mental disorders. Eur Psychiatry 2012, 27(2):68-80. European Psychiatric Association.
14. Cannon T.D., Cadenhead K., Cornblatt B., Woods S.W., Addington J., Walker E., et al. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiatry 2008, 65(1):28-37.
15. Carrión R.E., McLaughlin D., Goldberg T.E., Auther A.M., Olsen R.H., Olvet D.M., et al. Prediction of functional outcome in individuals at clinical high risk for psychosis. JAMA Psychiatry 2013, 70(11):1133-1142.
16. Collins P.Y., Patel V., Joestl S.S., March D., Insel T.R., Daar A.S., et al. Grand challenges in global mental health. Nature 2011, 475(7354):27-30.
17. Cornblatt B.A., Carrión R.E., Addington J., Seidman L., Walker E.F., Cannon T.D., et al. Risk factors for psychosis: impaired social and role functioning. Schizophr Bull 2012, 38(6):1247-1257.
18. David C.N., Greenstein D., Clasen L., Gochman P., Miller R., Tossell J.W., et al. Childhood onset schizophrenia: high rate of visual hallucinations. J Am Acad Child Adolesc Psychiatry 2011, 50(7):681-686.
19. De Girolamo G., Dagani J., Purcell R., Cocchi A., McGorry P.D. Age of onset of mental disorders and use of mental health services: needs, opportunities and obstacles. Epidemiol Psychiatr Sci 2012, 21(1):47-57.
20. Deutsche Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde (DGPPN) Behandlungsleitlinie Schizophrenie 2006, Steinkopff Verlag, Darmstadt.
21. Dragt S., Nieman D.H., Veltman D., Becker H.E., van de Fliert R., de Haan L., et al. Environmental factors and social adjustment as predictors of a first psychosis in subjects at ultra high risk. Schizophr Res 2011, 125(1):69-76.
22. The European Network of Schizophrenia Networks for the Study of Gene-Environment Interactions (EU-GEI) Schizophrenia aetiology: do gene-environment interactions hold the key?. Schizophr Res 2008, 102(1-3):21-26.
23. Fiori Nastro P., Schimmelmann B.G., Gebhardt E., Monducci E., Resch F., Koch E., et al. [Challenges in the early detection of psychosis in children and adolescents]. Riv Psichiatr 2012, 47(2):116-125.
24. Fusar-Poli P., Hobson R., Raduelli M., Balottin U. Reliability and validity of the comprehensive assessment of the at risk mental state, Italian version (CAARMS-I). Curr Pharm Des 2012, 18(4):386-391.
25. Fusar-Poli P., Borgwardt S., Bechdolf A., Addington J., Riecher-Rössler A., Schultze-Lutter F., et al. The psychosis high-risk state: a comprehensive state-of-the-art review. JAMA Psychiatry 2013, 70(1):107-120.
26. Fusar-Poli P., Byrne M., Badger S., Valmaggia L.R., McGuire P.K. Outreach and support in south London (OASIS), 2001-2011: ten years of early diagnosis and treatment for young individuals at high clinical risk for psychosis. Eur Psychiatry 2013, 28(5):315-326.
27. Fux L., Walger P., Schimmelmann B.G., Schultze-Lutter F. The schizophrenia proneness instrument, child and youth version (SPI-CY): practicability and discriminative validity. Schizophr Res 2013, 146(1-3):69-78.
28. Gaebel W., Möller H.J. European guidance-a project of the European Psychiatric Association. Eur Psychiatry 2012, 27:65-67.
29. Gater R., Jordanova V., Maric N., Alikaj V., Bajs M., Cavic T., et al. Pathways to psychiatric care in Eastern Europe. Br J Psychiatry 2005, 186:529-535.
30. González-Pinto A., Ruiz de Azúa S., Ibáñez B., Otero-Cuesta S., Castro-Fornieles J., Graell-Berna M., et al. Can positive family factors be protective against the development of psychosis?. Psychiatry Res 2011, 186(1):28-33.
31. Gore F.M., Bloem P.J., Patton G.C., Ferguson J., Joseph V., Coffey C., et al. Global burden of disease in young people aged 10-24years: a systematic analysis. Lancet 2011, 377(9783):2093-2102.
32. Gross G., Huber G., Klosterkötter J., Linz M. Bonner Skala für die Beurteilung von Basisymptomen 1987, Springer-Verlag, Berlin.
33. Häfner H., Riecher-Rössler A., Hambrecht M., Maurer K., Meissner S., Schmidtke A., et al. IRAOS: an instrument for the assessment of onset and early course of schizophrenia. Schizophr Res 1992, 6(3):209-223.
34. Häfner H., Maurer K., Löffler W., Riecher-Rössler A. The influence of age and sex on the onset and early course of schizophrenia. Br J Psychiatry 1993, 162:80-86.
35. Häfner H., Maurer K., Löffler W., Fätkenheuer B., an der Heiden W., Riecher-Rössler A., et al. The epidemiology of early schizophrenia. Influence of age and gender on onset and early course. Br J Psychiatry 1994, Suppl.(23):29-38.
36. Harrison P.J., Weinberger D.R. Schizophrenia genes, gene expression and neuropathology on the matter of their convergence. Mol Psychiatry 2005, 10(Suppl.3):40-68.
37. Hlastala S.A., McClellan J. Phenomenology and diagnostic stability of youths with atypical psychotic symptoms. J Child Adolesc Psychopharmacol 2005, 15(3):497-509.
38. Jackson D., Kirkbride J., Croudace T., Morgan C., Boydell J., Errazuriz A., et al. Meta-analytic approaches to determine gender differences in the age-incidence characteristics of schizophrenia and related psychoses. Int J Methods Psychiatr Res 2013, 22(1):36-45.
39. Jang J.H., Shin N.Y., Shim G., Park H.Y., Kim E., Jang G.E., et al. Longitudinal patterns of social functioning and conversion to psychosis in subjects at ultra-high risk. Aust N Z J Psychiatry 2011, 45(9):763-770.
40. Katsura M., Ohmuro N., Obara C., Kikuchi T., Ito F., Miyakoshi T., et al. A naturalistic longitudinal study of at-risk mental state with a 2.4-year follow-up at a specialized clinic setting in Japan. Schizophr Res 2014, 158(1-3):32-38. 10.1016/j.schres.2014.06.013.
41. Kay S.R., Fiszbein A., Opfer L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987, 13(2):261-276.
42. Kayser J., Tenke C.E., Kroppmann C.J., Alschuler D.M., Ben-David S., Fekri S., et al. Olfaction in the psychosis prodrome: electrophysiological and behavioral measures of odor detection. Int J Psychophysiol 2013, 90(2):190-206.
43. Kelleher I., Murtagh A., Molloy C., Roddy S., Clarke M.C., Harley M., et al. Identification and characterization of prodromal risk syndromes in young adolescents in the community: a population-based clinical interview study. Schizophr Bull 2012, 38(2):239-246.
44. Kelleher I., Keeley H., Corcoran P., Lynch F., Fitzpatrick C., Devlin N., et al. Clinicopathological significance of psychotic experiences in non-psychotic young people: evidence from four population-based studies. Br J Psychiatry 2012, 201(1):26-32.
45. Kim E., Jang J.H., Park H.Y., Shim G., Hwang J.Y., Kim S.N., et al. Pharmacotherapy and clinical characteristics of ultra-high-risk for psychosis according to conversion status: a naturalistic observational study. Early Interv Psychiatry 2012, 6(1):30-37.
46. Kirkbride J.B., Fearon P., Morgan C., Dazzan P., Morgan K., Tarrant J., et al. Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-center AeSOP study. Arch Gen Psychiatry 2006, 63(3):250-258.
47. Kirkbride J.B., Errazuriz A., Croudace T.J., Morgan C., Jackson D., Boydell J., et al. Incidence of schizophrenia and other psychoses in England, 1950-2009: a systematic review and meta-analyses. PLoS One 2012, 7(3):e31660.
48. Kiss I., Kelemen O., Kéri S. Decreased peripheral expression of neuregulin 1 in high-risk individuals who later converted to psychosis. Schizophr Res 2012, 135(1-3):198-199.
49. Kline E., Schiffman J. Psychosis risk screening: a systematic review. Schizophr Res 2014, 158(1-3):11-18. 10.1016/j.schres.2014.06.036.
50. Klosterkötter J., Hellmich M., Steinmeyer E.M., Schultze-Lutter F. Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry 2001, 58(2):158-164.
51. Klosterkötter J., Schultze-Lutter F., Bechdolf A., Ruhrmann S. Prediction and prevention of schizophrenia: what has been achieved and where to go next?. World Psychiatry 2011, 10(3):165-174.
52. Koike S., Takano Y., Iwashiro N., Satomura Y., Suga M., Nagai T., et al. A multimodal approach to investigate biomarkers for psychosis in a clinical setting: the integrative neuroimaging studies in schizophrenia targeting for early intervention and prevention (IN-STEP) project. Schizophr Res 2013, 143(1):116-124.
53. Kotlicka-Antczak M., Pawełczyk T., Rabe-Jabłońska J., Pawełczyk A. PORT (Programme of Recognition and Therapy): the first Polish recognition and treatment programme for patients with an at-risk mental state. Early Interv Psychiatry 2014, [Epub ahead of print]. 10.1111/eip.12146.
54. Koutsouleris N., Riecher-Rössler A., Meisenzahl E.M., Smieskova R., Studerus E., Kambeitz-Ilankovic L., et al. Detecting the psychosis prodrome across high-risk populations using neuroanatomical biomarkers. Schizophr Bull 2014, [Epub ahead of print]. 10.1093/schbul/sbu078.
55. Koutsouleris N., Meisenzahl E.M., Davatzikos C., Bottlender R., Frodl T., Scheuerecker J., et al. Use of neuroanatomical pattern classification to identify subjects in at-risk mental states of psychosis and predict disease transition. Arch Gen Psychiatry 2009, 66(7):700-712.
56. Lam M.M., Hung S.F., Chen E.Y. Transition to psychosis: 6-month follow-up of a Chinese high-risk group in Hong Kong. Aust N Z J Psychiatry 2006, 40(5):414-420.
57. Lee J., Rekhi G., Mitter N., Bong Y.L., Kraus M.S., Lam M., et al. The longitudinal youth at risk study (LYRIKS)-an Asian UHR perspective. Schizophr Res 2013, 151(1-3):279-283.
58. Lemos-Giráldez S., Vallina-Fernández O., Fernández-Iglesias P., Vallejo-Seco G., Fonseca-Pedrero E., Paíno-Piñeiro M., et al. Symptomatic and functional outcome in youth at ultra-high risk for psychosis: a longitudinal study. Schizophr Res 2009, 115(2-3):121-129.
59. Lindgren M., Manninen M., Kalska H., Mustonen U., Laajasalo T., Moilanen K., et al. Predicting psychosis in a general adolescent psychiatric sample. Schizophr Res 2014, 158(1-3):1-6. 10.1016/j.schres.2014.06.028.
60. Manninen M., Lindgren M., Therman S., Huttunen M., Ebeling H., Moilanen I., et al. Clinical high-risk state does not predict later psychosis in a delinquent adolescent population. Early Interv Psychiatry 2014, 8(1):87-90.
61. Marshall M., Lewis S., Lockwood A., Drake R., Jones P., Croudace T. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch Gen Psychiatry 2005, 62(9):975-983.
62. Mason O., Startup M., Halpin S., Schall U., Conrad A., Carr V. Risk factors for transition to first episode psychosis among individuals with 'at-risk mental states'. Schizophr Res 2004, 71(2-3):227-237.
63. Maurer K., Hörrmann F., Trendler G., Schmidt M., Haefner H. [Identification of psychosis risk by the Early Recognition Inventory (ERIraos)-Description of the schedules and preliminary results on reliability and validity of the checklist]. Nervenheilkunde 2006, 25(1):11-16.
64. McGlashan T., Walsh B., Woods S. The psychosis-risk syndrome. Handbook for diagnosis and follow-up 2010, Oxford University Press, New York, NY.
65. McGrath J., Saha S., Welham J., El S.O., MacCauley C., Chant D. A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology. BMC Med 2004, 2:13.
66. Meneghelli A., Alpi A., Cascio M.T., Häfner H., Maurer K., Preti A., et al. Italian validation of the early recognition inventory for the retrospective assessment of the onset of schizophrenia checklist: reliability, validity and instructions for use. J Psychopathol 2013, 19(1-2):1-9.
67. Michel C, Ruhrmann S, Schimmelmann BG, Klosterkötter J, Schultze-Lutter F. A stratified model for psychosis prediction in clinical practice. Schizophr Bull 40(6):1533-42, doi:10.1093/schbul/sbu025.
68. Michel C, Schultze-Lutter F, Schimmelmann BG. Screening instruments in child and adolescent psychiatry: general and methodological considerations. Eur Child Adolesc Psychiatry 23(9):725-7, doi:10.1007/s00787-014-0608-x.
69. Morrison A.P., French P., Walford L., Lewis S.W., Kilcommons A., Green J., et al. Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomised controlled trial. Br J Psychiatry 2004, 185:291-297.
70. Morrison A.P., French P., Parker S., Roberts M., Stevens H., Bentall R.P., et al. Three-year follow-up of a randomized controlled trial of cognitive therapy for the prevention of psychosis in people at ultrahigh risk. Schizophr Bull 2007, 33(3):682-687.
71. Morrison A.P., Stewart S.L., French P., Bentall R.P., Birchwood M., Byrne R., et al. Early detection and intervention evaluation for people at high-risk of psychosis-2 (EDIE-2): trial rationale, design and baseline characteristics. Early Interv Psychiatry 2011, 5(1):24-32.
72. Morrison A.P., French P., Stewart S.L., Birchwood M., Fowler D., Gumley A.I., et al. Early detection and intervention evaluation for people at risk of psychosis: multisite randomised controlled trial. BMJ 2012, 344:e2233.
73. Mrazek P.J., Haggerty H.J. Reducing risks for mental disorders: frontiers for preventive research 2013, Academy Press, Washington, DC.
74. National Institute for Health, Clinical Excellence (NICE) Psychosis with coexisting substance misuse: assessment and management in adults and young people 2011, [Online], [Available at: https://www.nice.org.uk/guidance/published?type=Guidelines (Accessed: 25 August 2014)].
75. National Institute for Health, Clinical Excellence (NICE) Psychosis and schizophrenia in children and young people: recognition and management 2013, [Online], [Available at: https://www.nice.org.uk/guidance/published?type=Guidelines (Accessed: 25 August 2014)].
76. National Institute for Health, Clinical Excellence (NICE) Psychosis and schizophrenia in adults: treatment and management 2014, [Online], [Available at: https://www.nice.org.uk/guidance/published?type=Guidelines (Accessed: 25 August 2014)].
77. Nelson B., Yuen K., Yung A.R. Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis?. Schizophr Res 2011, 125(1):62-68.
78. Nelson B., Thompson A., Yung A.R. Basic self-disturbance predicts psychosis onset in the ultra high risk for psychosis "prodromal" population. Schizophr Bull 2012, 38(6):1277-1287.
79. Nelson B., Yuen H.P., Wood S.J., Lin A., Spiliotacopoulos D., Bruxner A., et al. Long-term follow-up of a group at ultra high risk ("prodromal") for psychosis: the PACE 400 study. JAMA Psychiatry 2013, 70(8):793-802.
80. Nieman DH, Ruhrmann S, Dragt S, Soen F, van Tricht MJ, Koelman JH, et al. Psychosis prediction: stratification of risk estimation with information-processing and premorbid functioning variables. Schizophr Bull 40(6):1482-90, doi:10.1093/schbul/sbt145.
81. Olesen J., Gustavsson A., Svensson M., Wittchen H.U., Jönsson B., CDBE2010 study group, et al. The economic cost of brain disorders in Europe. Eur J Neurol 2012, 19(1):155-162.
82. Overall J.E., Gorham D.R. The brief psychiatric rating scale. Psychol Rep 1962, 10:799-812.
83. Perälä J., Suvisaari J., Saarni S.I., et al. Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch Gen Psychiatry 2007, 64(1):19-28.
84. Phillips L.J., Yung A.R., McGorry P.D. Identification of young people at risk of psychosis: validation of Personal Assessment and Crisis Evaluation Clinic intake criteria. Aust N Z J Psychiatry 2000, 34(Suppl.):164-169.
85. Raballo A., Meneghelli A., Cocchi A., Sisti D., Rocchi M.B., Alpi A., et al. Shades of vulnerability: latent structures of clinical caseness in prodromal and early phases of schizophrenia. Eur Arch Psychiatry Clin Neurosci 2014, 264(2):155-169.
86. Riecher-Rössler A., Aston J., Ventura J., Merlo M., Borgwardt S., Gschwandtner U., et al. [The Basel Screening Instrument for Psychosis (BSIP): development, structure, reliability and validity]. Fortschr Neurol Psychiatr 2008, 76(4):207-216.
87. Riecher-Rössler A., Pflueger M.O., Aston J., Borgwardt S.J., Brewer W.J., Gschwandtner U., et al. Efficacy of using cognitive status in predicting psychosis: a 7-year follow-up. Biol Psychiatry 2009, 66(11):1023-1030.
88. Ross R.G., Heinlein S., Tregellas H. High rates of comorbidity are found in childhood-onset schizophrenia. Schizophr Res 2006, 88(1-3):90-95.
89. Rössler W., Salize H.J., van Os J., Riecher-Rössler A. Size of burden of schizophrenia and psychotic disorders. Eur Neuropsychopharmacol 2005, 15(4):399-409.
90. Rubio J.M., Sanjuán J., Flórez-Salamanca L., Cuesta M.J. Examining the course of hallucinatory experiences in children and adolescents: a systematic review. Schizophr Res 2012, 138(2-3):248-254.
91. Ruhrmann S., Bechdolf A., Kühn K.U., Wagner M., Schultze-Lutter F., Janssen B., et al. Acute effects of treatment for prodromal symptoms for people putatively in a late initial prodromal state of psychosis. Br J Psychiatry 2007, 51(Suppl.):88-95.
92. Ruhrmann S., Schultze-Lutter F., Salokangas R.K., Heinimaa M., Linszen D., Dingemans P., et al. Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study. Arch Gen Psychiatry 2010, 67(3):241-251.
93. Salokangas R.K., Patterson P., Heinimaa M., Svirskis T., From T., Vaskelainen L., et al. Perceived negative attitude of others predicts transition to psychosis in patients at risk of psychosis. Eur Psychiatry 2012, 27(4):264-266.
94. Schaeffer J.L., Ross R.G. Childhood-onset schizophrenia: premorbid and prodromal diagnostic and treatment histories. J Am Acad Child Adolesc Psychiatry 2002, 41(5):538-545.
95. Schimmelmann B.G., Schultze-Lutter F. Early detection and intervention of psychosis in children and adolescents: urgent need for studies. Eur Child Adolesc Psychiatry 2012, 21(5):239-241.
96. Schimmelmann B.G., Conus P., Cotton S., McGorry P.D., Lambert M. Pre-treatment, baseline, and outcome differences between early-onset and adult-onset psychosis in an epidemiological cohort of 636 first-episode patients. Schizophr Res 2007, 95(1-3):1-8.
97. Schimmelmann B.G., Huber C.G., Lambert M., Cotton S., McGorry P.D., Conus P. Impact of duration of untreated psychosis on pre-treatment, baseline, and outcome characteristics in an epidemiological first-episode psychosis cohort. J Psychiatr Res 2008, 42(12):982-990.
98. Schimmelmann B.G., Schmidt S.J., Carbon M., Correll C.U. Treatment of adolescents with early-onset schizophrenia spectrum disorders: in search of a rational, evidence-informed approach. Curr Opin Psychiatry 2013, 26(2):219-230.
99. Schimmelmann B.G., Walger P., Schultze-Lutter F. The significance of at-risk symptoms for psychosis in children and adolescents. Can J Psychiatry 2013, 58(1):32-40.
100. Schlosser D.A., Jacobson S., Chen Q., Sugar C.A., Niendam T.A., Li G., et al. Recovery from an at-risk state: clinical and functional outcomes of putatively prodromal youth who do not develop psychosis. Schizophr Bull 2012, 38(6):1225-1233.
101. Schmidt S.J., Grunert V.M., Schimmelmann B.G., Schultze-Lutter F., Michel C. Differences in coping, self-efficacy, and external control beliefs between patients at-risk for psychosis and patients with first-episode psychosis. Psychiatry Res 2014, 219(1):95-102.
102. Schultze-Lutter F. Subjective symptoms of schizophrenia in research and the clinic: the basic symptom concept. Schizophr Bull 2009, 35(1):5-8.
103. Schultze-Lutter F., Ruhrmann S., Klosterkötter J. Evolving psychosis. Different stages, different treatments 2006, 104-123. Routledge, London, New York. J.O. Johannessen, B. Martindale, J. Cullberg (Eds.).
104. Schultze-Lutter F., Addington J., Ruhrmann S., Klosterkötter J. Schizophrenia proneness instrument adult version (SPI-A) 2007, Giovanni Fioriti Editore s.r.l, Rome.
105. Schultze-Lutter F., Klosterkötter J., Picker H., Steinmeyer E.M., Ruhrmann S. Predicting first-episode psychosis by basic symptom criteria. Clin Neuropsychiatry 2007, 4(1):11-22.
106. Schultze-Lutter F., Ruhrmann S., Berning J., Maier W., Klosterkötter J. Basic symptoms and ultrahigh risk criteria: symptom development in the initial prodromal state. Schizophr Bull 2010, 36(1):182-191.
107. Schultze-Lutter F., Resch F., Koch E., Schimmelmann B.G. Früherkennung von Psychosen bei Kindern und Adoleszenten-sind entwicklungsbezogene Besonderheiten ausreichend berücksichtigt?. Z Kinder Jugendpsychiatr Psychother 2011, 39(5):301-311.
108. Schultze-Lutter F., Ruhrmann S., Fusar-Poli P., Bechdolf A., Schimmelmann B.G., Klosterkötter J. Basic symptoms and the prediction of first-episode psychosis. Curr Pharm Des 2012, 18(4):351-357.
109. Schultze-Lutter F., Marshall M., Koch E. Schizophrenia proneness instrument, child and youth version; extended English translation (SPI-CY EET) 2012, Giovanni Fioriti Editore s.r.l, Rome.
110. Schultze-Lutter F., Schimmelmann B.G., Ruhrmann S., Michel C. 'A rose is a rose is a rose', but at-risk criteria differ. Psychopathology 2013, 46(2):75-87.
111. Schultze-Lutter F., Michel C., Schimmelmann B.G. Prevalence of at-risk criteria of psychosis in children and adolescents, and in young adults: results from two Swiss community samples. Schizophr Res 2014, 153(Suppl.1):134. [Abstract].
112. Schultze-Lutter F., Klosterkötter J., Ruhrmann S. Improving the clinical prediction of psychosis by combining ultra-high risk criteria and cognitive basic symptoms. Schizophr Res 2014, 154(1-3):100-106.
113. Simon A.E., Grädel M., Cattapan-Ludewig K., Gruber K., Ballinari P., Roth B., et al. Cognitive functioning in at-risk mental states for psychosis and 2-year clinical outcome. Schizophr Res 2012, 142(1-3):108-115.
114. Thorup A., Waltoft B.L., Pedersen C.B., Mortensen P.B., Nordentoft M. Young males have a higher risk of developing schizophrenia: a Danish register study. Psychol Med 2007, 37(4):479-484.
115. Tolbert H.A. Psychoses in children and adolescents: a review. J Clin Psychiatry 1996, 57(Suppl.3):4-8. [discussion 46-7].
116. van der Gaag M., Nieman D.H., Rietdijk J., Dragt S., Ising H.K., Klaassen R.M., et al. Cognitive behavioral therapy for subjects at ultrahigh risk for developing psychosis: a randomized controlled clinical trial. Schizophr Bull 2012, 38(6):1180-1188.
117. van Os J., Kapur S. Schizophrenia. Lancet 2009, 374(9690):635-645.
118. van Os J., Kenis G., Rutten B.P. The environment and schizophrenia. Nature 2010, 468(7321):203-212.
119. Velthorst E., Nieman D.H., Becker H.E., van de Fliert R., Dingemans P.M., Klaassen R., et al. Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis. Schizophr Res 2009, 109(1-3):60-65.
120. Velthorst E., Derks E.M., Schothorst P., Becker H., Durston S., Ziermans T., et al. Quantitative and qualitative symptomatic differences in individuals at Ultra-High Risk for psychosis and healthy controls. Psychiatry Res 2013, 210(2):432-437.
121. Velthorst E., Nelson B., Wiltink S., de Haan L., Wood S.J., Lin A., et al. Transition to first episode psychosis in ultra high risk populations: does baseline functioning hold the key?. Schizophr Res 2013, 143(1):132-137.
122. Walder D.J., Mittal V., Trotman H.D., McMillan A.L., Walker E.F. Neurocognition and conversion to psychosis in adolescents at high-risk. Schizophr Res 2008, 101(1-3):161-168.
123. Welsh P., Tiffin P.A. The 'at-risk mental state' for psychosis in adolescents: clinical presentation, transition and remission. Child Psychiatry Hum Dev 2014, 45(1):90-98.
124. Whithing J., Rutjes A.W., Dinnes J., Reitsma B.J., Bossuyt P.M., Kleijnen J. Development and validation of methods assessing the quality of diagnostic accuracy studies. Health Tech Assess 2004, 8(25):1-234. [iii].
125. Wittchen H.U., Jacobi F., Rehm J., Gustavsson A., Svensson M., Jönsson B., et al. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 2011, 21(9):655-679.
126. Woodberry K.A., Seidman L.J., Giuliano A.J., Verdi M.B., Cook W.L., McFarlane W.R. Neuropsychological profiles in individuals at clinical high risk for psychosis: relationship to psychosis and intelligence. Schizophr Res 2010, 123(2-3):188-198.
127. World Health Organization Prevention of mental disorders: effective interventions and policy options 2004, World Health Organization, Geneva.
128. Yung A.R., McGorry P.D. The initial prodrome in psychosis: descriptive and qualitative aspects. Aust N Z J Psychiatry 1996, 30(5):587-599.
129. Yung A.R., Phillips L.J., Yuen H.P., Francey S.M., McFarlane C.A., Hallgren M., et al. Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group. Schizophr Res 2003, 60(1):21-32.
130. Yung A.R., Yuen H.P., McGorry P.D., Phillips L.J., Kelly D., Dell'Olio M., et al. Mapping the onset of psychosis: the comprehensive assessment of at-risk mental states. Aust N Z J Psychiatry 2005, 39(11-12):964-971.
131. Yung A.R., Phillips L.J., Simmons M.B., Ward J., Thompson P., French P., et al. CAARMS. Comprehensive assessment at risk mental states 2006, The PACE Clinic, ORYGEN Research Centre, University of Melbourne, Department of Psychiatry, Parkville Victoria.
132. Yung A.R., Stanford C., Cosgrave E., Killackey E., Phillips L., Nelson B., et al. Testing the ultra high risk (prodromal) criteria for the prediction of psychosis in a clinical sample of young people. Schizophr Res 2006, 84(1):57-66.
133. Yung A.R., Nelson B., Stanford C., Simmons M.B., Cosgrave E.M., Killackey E., et al. Validation of "prodromal" criteria to detect individuals at ultra high risk of psychosis: 2-year follow-up. Schizophr Res 2008, 105(1-3):10-17.
134. Zhang T., Li H., Woodberry K.A., Seidman L.J., Zheng L., Li H., et al. Prodromal psychosis detection in a counseling center population in China: an epidemiological and clinical study. Schizophr Res 2014, 152(2-3):391-399.
135. Ziermans T.B., Schothorst P.F., Sprong M., van Engeland H. Transition and remission in adolescents at ultra-high risk for psychosis. Schizophr Res 2011, 126(1-3):58-64.
136. Zimmermann R., Gschwandtner U., Wilhelm F.H., Pflueger M.O., Riecher-Rössler A., Fuhr P. EEG spectral power and negative symptoms in at-risk individuals predict transition to psychosis. Schizophr Res 2010, 123(2-3):208-216.